Myocardial Perfusion Imaging artifacts: centric h-EPI and its sensitivity to frequency errors
© Ferreira et al; licensee BioMed Central Ltd. 2010
Published: 21 January 2010
Clinical myocardial perfusion often uses Echo-Planar-Imaging, in a multishot "hybrid" variety using centre-out phase-encode-order ("h-EPI") [S Ding, et al., MRM, 39:514, 1998] for robustness against susceptibility dephasing of signal within pixels, especially during first-pass of paramagnetic Contrast-Agent (CA). However, this sequence may be sensitive to frequency errors.
We examined the artifacts, specifically whether they could cause subendocardial Dark Rim Artifacts (DRA) mimicking perfusion defects in patients.
Clinical h-EPI stress/rest perfusion studies were reviewed after phantom images drew our attention to the off-resonance sensitivity of the h-EPI technique. All work was done at 1.5 T (Avanto, Siemens); h-EPI (4 echoes); TR/TE 5.1/1.7 ms; pixel size 2.8 × 2.8 × 8 mm; flip angle 30 deg; bandwidth 1860 Hz/pixel; saturation-recovery (TI = 90 ms); TSENSE with R = 2; Gd-based CA 0.1 mmol/kg at 3.5 ml/s. The sequence was also used to image across a hollow diamagnetic gelatine cylinder containing 12.5 mmol/L Gd-DTPA solution, forming a magnetostatic and relaxation-time model of the LV during CA first-pass. Phantom images were acquired at two scanner reference frequencies, approximating the gelatine "myocardium" and LV "blood" frequencies. For comparison, the phantom was also imaged with a balanced-SSFP perfusion sequence. For one in-vivo perfusion study, accumulated phase-errors corresponding to scanner reference frequency offsets were applied to the stored raw-data and images were repeat-reconstructed to examine h-EPI's sensitivity to the frequency used for the patient.
In clinical use, the h-EPI centre-out phase-encode order is sufficiently sensitive to frequency offsets that phase-encode "splitting" of the endocardial border may degrade image clarity and even generate subendocardial DRAs along the phase encode direction.
This article is published under license to BioMed Central Ltd.